Extended Data Fig. 4: Screening microbiota strains with altered abundances in the microbiota of GNSR mutants for CYP71A12 induction potential and plant phenotypes. | Nature Plants

Extended Data Fig. 4: Screening microbiota strains with altered abundances in the microbiota of GNSR mutants for CYP71A12 induction potential and plant phenotypes.

From: Plant microbiota feedbacks through dose-responsive expression of general non-self response genes

Extended Data Fig. 4: Screening microbiota strains with altered abundances in the microbiota of GNSR mutants for CYP71A12 induction potential and plant phenotypes.

(A) CYP71A12 induction by nine microbiota strains and the foliar pathogen P. syringae pv. tomato DC3000 (Pst) upon exposure of A. thaliana pCYP71A12::GUS reporter seedlings to bacterial suspensions in a fluorometric assay screen for one day. Included were microbiota strains that were affected by mutations in GNSR components in a microbiota context (highlighted by grey diamonds in Fig. 1b). Vertical plot line indicates mean fluorescence of mock-treated plants on the same plate as the indicated treatment. Boxplot bars indicate median, hinges indicate first and third quartile, whiskers indicate smallest/largest value within 1.5 × IQR (interquartile range). Data from one experiment with n = 6–7 plants per condition (indicated above x-axis). Statistical significance was assessed by two-sided t-test with Bonferroni correction using titer “1×” as reference group (***: P-value ≤ 0.001, **: P-value ≤ 0.01, and *: P-value ≤ 0.05). (B) Representative images of pCYP71A12::GUS reporter plants one day after treatment with indicated bacteria. Pictures were taken immediately before performing the fluorometric assay. (C) Representative images of pCYP71A12::GUS reporter plants three days after treatment (3 d), where disease phenotype caused by Serratia Leaf50 is enhanced. Treatment suspensions of leaf microbiota strains or Pst were prepared at a 10× titer. (A, B) Indicated titers of 1×, 10×, and 100× correspond to bacterial treatment suspensions adjusted to an OD600 of 0.002, 0.02, and 0.2 before treatment, respectively.

Source data

Back to article page